NEAT1 and glioblastoma: The results showed that rates of apoptosis were the most significantly increased in the si‐NEAT1 groups with TMZ treatment (Figure 1I–K), revealing knockdown of NEAT1 could promote the sensitivity of GBM cells to TMZ.